Home ⟩ Insights

Insights

analyst-ratings

1 min read • September 22, 2021

Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Raises Price Target to $81

1 min read • September 17, 2021

Cantor Fitzgerald Maintains Neutral on Aurora Cannabis, Lowers Price Target to C$8.3

1 min read • August 19, 2021

Raymond James Initiates Coverage On Decibel Cannabis Co with Outperform Rating

3 min read • August 13, 2021

Cantor Remains Neutral on Charlotte’s Web, cbdMD and CV Science, Why These CBD Stocks May Benefit If Cannabis Reform Actually Happens

2 min read • August 12, 2021

Cantor: ‘Aleafia Continues To Post Solid Momentum,’ Firm Bullish But Lowers Price Target Due To Cannabis Sector Derating

4 min read • August 6, 2021

Cantor Fitzgerald Lowers Price On Trulieve Cannabis Corp Ahead Of Q2 Report, Still Among Top US Picks

1 min read • August 5, 2021

Needham Maintains Buy on Trulieve Cannabis, Raises Price Target to $68.25

2 min read • July 27, 2021

Cantor Fitzgerald Lowers Price Target On Tilray Cannabis Co Ahead Of Earnings Report, Sees Several Catalysts Including U.S. Plans

3 min read • July 19, 2021

Cantor Fitzgerald Lowers Price Target As Canadian Cannabis Producer Organigram Posts Q3 Earnings

1 min read • July 14, 2021

Desjardins Initiates Coverage On IM Cannabis with Buy Rating, Announces Price Target of C$10.5

1 min read • July 7, 2021

Jefferies Initiates Coverage On Trulieve Cannabis with Buy Rating, Announces Price Target of $62

3 min read • June 18, 2021

Cantor Updates Ratings On Several Cannabis And CBD Stocks – MedMen, Jushi, cbdMD, CV Sciences

Latest Headlines

5 min read • September 2, 2026

Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights

10 min read • September 2, 2026

Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround

3 min read • September 2, 2026

Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows

2 min read • September 2, 2026

UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share

7 min read • September 2, 2026

Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation

3 min read • September 1, 2026

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

8 min read • September 1, 2026

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

2 min read • September 1, 2026

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.